Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux

Brazilian Journal of Medical and Biological Research

Volumn 49, Issue 7, 2016, Pages

  Liu, C ^a   Wang, H ^a   Liu, K ^b  

^a Ji ning First People s Hospital of Shandong Province   (China)

^b Ping du People s Hospital of Shandong Province   (China)

Author keywords

Adult; Gastroesophageal reflux disease; Meta analysis; Proton pump inhibitors

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;

CHRONIC COUGH; CONTROLLED CLINICAL TRIAL (TOPIC); COUGHING; DRUG EFFICACY; DYSPHAGIA; DYSPHONIA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; GLOBUS; HUMAN; LARYNGOPHARYNGEAL REFLUX; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SORE THROAT; SYMPTOM ASSESSMENT; SYSTEMATIC REVIEW; ADULT; FEMALE; MALE; PLACEBO EFFECT; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; FEMALE; HUMANS; LARYNGOPHARYNGEAL REFLUX; MALE; PLACEBO EFFECT; PROTON PUMP INHIBITORS; TREATMENT OUTCOME;

EID: 84979020996     PISSN: None     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20165149     Document Type: Review

References (23)

1. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101: 1-78, doi:10.1002/lary.5541011220.
2. Wong RK, Hanson DG, Waring PJ, Shaw G. ENT manifestations of gastroesophageal reflux. Am J Gastroenterol 2000; 95: S15-S22, doi:10.1016/S0002-9270(00)01074-1.
3. Vardar R, Varis A, Bayrakci B, Akyildiz S, Kirazli T, Bor S. Relationship between history, laryngoscopy and esophagogastroduodenoscopy for diagnosis of laryngopharyngeal reflux in patients with typical GERD. Eur Arch Otorhinolaryngol 2012; 269: 187-191, doi:10.1007/s00405-011-1748-y.
4. Sen P, Georgalas C, Bhattacharyya AK. A systematic review of the role of proton pump inhibitors for symptoms of laryngopharyngeal reflux. Clin Otolaryngol, 2006; 31: 20-24, doi:10.1111/j.1749-4486.2006.01134.x.
5. Shaheen NJ, Crockett SD, Bright SD, Madanick RD, Buckmire R, Couch M, et al. Randomised clinical trial: high-dose acid suppression for chronic cough -a doubleblind, placebo-controlled study. Aliment Pharmacol Ther 2011; 33: 225-234, doi:10.1111/j.1365-2036.2010.04511.x.
6. Reichel O, Dressel H, Wiederanders K, Issing WJ. Doubleblind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux. Otolaryngol Head Neck Surg 2008; 139: 414-420, doi:10.1016/j.otohns.2008.06.003.
7. Wo JM, Koopman J, Harrell SP, Parker K, Winstead W, Lentsch E. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux. Am J Gastroenterol 2006; 101: 1972-1978, doi:10.1111/j.1572-0241.2006.00693.x.
8. Vaezi MF, Richter JE, Stasney CR, Spiegel JR, Iannuzzi RA, Crawley JA, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006; 116: 254-260, doi:10.1097/01.mlg.0000192173.00498.ba.
9. Steward DL, Wilson KM, Kelly DH, Patil MS, Schwartzbauer HR, Long JD, et al. Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 2004; 131: 342-350, doi:10.1016/j.otohns.2004.03.037.
10. Eherer AJ, Habermann W, Hammer HF, Kiesler K, Friedrich G, Krejs GJ. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled doubleblind crossover study. Scand J Gastroenterol 2003; 38: 462-467, doi:10.1080/00365520310001860.
11. El-Serag HB, Lee P, Buchner A, Inadomi JM, Gavin M, McCarthy DM. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001; 96: 979-983, doi:10.1111/j.1572-0241.2001.03681.x.
12. Ours TM, Kavuru MS, Schilz RJ, Richter JE. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999; 94: 3131-3138, doi:10.1111/j.1572-0241.1999.01504.x.
13. Bak YT. Management strategies for gastroesophageal reflux disease. J Gastroenterol Hepatol 2004;19: S49-S53, doi:10.1111/j.1440-1746.2004.03587.x.
14. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice 2002; 16: 274-277, doi:10.1016/S0892-1997(02)00097-8.
15. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001; 111: 1313-1317, doi:10.1097/00005537-200108000-00001.
16. Gatta L, Vaira D, Sorrenti G, Zucchini S, Sama C, Vakil N. Meta-analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007; 25: 385-392, doi:10.1111/j.1365-2036.2006.03213.x.
17. Qadeer MA, Phillips CO, Lopez AR, Steward DL, Noordzij JP, Wo JM, et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol 2006; 101: 2646-2654, doi:10.1111/j.1572-0241.2006.00844.x.
18. Noordzij JP, Khidr A, Evans BA, Desper E, Mittal RK, Reibel JF, et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001; 111: 2147-2151, doi:10.1097/00005537-200112000-00013.
19. Langevin S, Ngo H. GERD-induced ENT symptoms: A prospective placebo controlled study with omeprazole 40 mg a day. Gastroenterology 2001; 120: A16, doi:10.1016/S0016-5085(08)80080-7.
20. Chiba T, Kudara N, Abiko Y, Endo M, Suzuki K, Sugai T, et al. Effects of proton pump inhibitors in patients with laryngopharyngeal reflux disease. Hepatogastroenterology 2011; 58: 1580-1582.
21. Park W, Hicks DM, Khandwala F, Richter JE, Abelson TI, Milstein C, et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 2005; 115: 1230-1238, doi:10.1097/01. MLG.0000163746.81766.45.
22. Qadeer MA, Swoger J, Milstein C, Hicks DM, Ponsky J, Richter JE, et al. Correlation between symptoms and laryngeal signs in laryngopharyngeal reflux. Laryngoscope 2005; 115: 1947-1952, doi:10.1097/01.mlg.0000176547.90094.ac.
23. Noordzij JP, Khidr A, Desper E, Meek RB, Reibel JF, Levine PA. Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscope 2002; 112: 2192-2195, doi:10.1097/00005537-200212000-00013.